CUSIP: 37185X106
Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / CL A COM
-
Total 13F shares
-
21,647,254
-
Share change
-
+1,025,377
-
Total reported value
-
$37,666,166
-
Price per share
-
$1.74
-
Number of holders
-
68
-
Value change
-
+$1,546,002
-
Number of buys
-
34
-
Number of sells
-
28
Quarterly Holders Quick Answers
What is CUSIP 37185X106?
CUSIP 37185X106 identifies GENN - GENESIS HEALTHCARE INC - CL A COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2017
-
Previous quarter:
Q1 2017
Recent filing periods for CUSIP 37185X106:
Institutional Holders of GENESIS HEALTHCARE INC - CL A COM (GENN) as of Q2 2017
As of 30 Jun 2017,
GENESIS HEALTHCARE INC - CL A COM (GENN) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,647,254 shares.
The largest 10 holders included
Columbia Pacific Advisors, LLC, HighTower Advisors, LLC, BlackRock Inc., JPMORGAN CHASE & CO, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, PANAGORA ASSET MANAGEMENT INC, VANGUARD GROUP INC, Forward Management, LLC, and NORTHERN TRUST CORP.
This page lists
68
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.